{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:50:16Z","timestamp":1761630616752},"reference-count":71,"publisher":"Frontiers Media SA","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1204,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1111\/j.1432-2277.2012.01490.x","type":"journal-article","created":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T14:39:14Z","timestamp":1337092754000},"page":"633-645","source":"Crossref","is-referenced-by-count":24,"title":["Prevention of antibody-mediated kidney transplant rejection"],"prefix":"10.3389","volume":"25","author":[{"given":"Christian","family":"Morath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Opelz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caner","family":"S\u00fcsal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2012,5,15]]},"reference":[{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB1|cit1","unstructured":"2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD."},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB2|cit2","unstructured":"Eurotransplant International Foundation Annual Report 2010 Edited by Arie Oosterlee and Axel Rahmel"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/TP.0b013e31817c90f5","article-title":"Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients","volume":"86","author":"Fuggle","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB4|cit4","unstructured":"Collaborative Transplant Study, University of Heidelberg, Germany http:\/\/www.ctstransplant.org"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.humimm.2009.04.013","article-title":"Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report","volume":"70","author":"S\u00fcsal","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure","volume":"9","author":"Hidalgo","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/ndt\/13.8.2027","article-title":"Sensitization to human leukocyte antigen before and after the introduction of erythropoietin","volume":"13","author":"Vella","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/TP.0b013e3181a9ec89","article-title":"A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients","volume":"88","author":"Meier-Kriesche","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"\u201cNatural\u201d human leukocyte antigen antibodies found in nonalloimmunized healthy males","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/TP.0b013e31816b3ed1","article-title":"Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients","volume":"85","author":"van den Berg-Loonen","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/TP.0b013e3181a5e034","article-title":"Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads","volume":"87","author":"Amico","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/TP.0b013e3182100f77","article-title":"No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report","volume":"91","author":"S\u00fcsal","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1600-6143.2011.03560.x","article-title":"Mastering the risk of HLA antibodies in kidney transplantation: an algorithm based on pretransplant single-antigen flow bead techniques","volume":"11","author":"Lefaucheur","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/00007890-200204270-00014","article-title":"Kidney graft failure and presensitization against HLA class I and class II antigens","volume":"73","author":"S\u00fcsal","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.TP.0000103725.72023.D7","article-title":"It takes six to boogie: allocating cadaver kidneys in Eurotransplant","volume":"77","author":"Doxiadis","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/TP.0b013e3181b04a5f","article-title":"Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program","volume":"88","author":"Claas","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-6143.2009.03001.x","article-title":"Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols","volume":"10","author":"Montgomery","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB20|cit20","article-title":"Desensitization of HLA-incompatible kidney recipients","volume":"365","author":"Morath","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/01.TP.0000090868.88895.E0","article-title":"Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients","volume":"76","author":"Zachary","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1034\/j.1600-6143.2002.20809.x","article-title":"Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg)","volume":"2","author":"Glotz","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/TP.0b013e318198a376","article-title":"Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab","volume":"87","author":"Beimler","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/j.1600-6143.2010.03226.x","article-title":"Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation","volume":"10","author":"Bartel","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-199402270-00014","article-title":"Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ","volume":"57","author":"Tyan","year":"1994","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00007890-199308000-00015","article-title":"Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients","volume":"56","author":"Glotz","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1111\/j.1600-6143.2005.01056.x","article-title":"IVIG and HLA antibodies. Evidence for inhibition of complement activation but not for anti-idiotypic activity","volume":"5","author":"Watanabe","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-3046.2004.00214.x","article-title":"Transplanting patients with a positive donor-specific crossmatch: a single center\u2019s perspective","volume":"8","author":"Montgomery","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0140-6736(89)91672-3","article-title":"Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation","volume":"1","author":"Palmer","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(96)03452-6","article-title":"Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation","volume":"348","author":"Higgins","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/01.TP.0000148732.26761.FA","article-title":"Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients","volume":"79","author":"Lorenz","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/ndt\/17.8.1503","article-title":"Peri-operative immunoadsorption in sensitized renal transplant recipients","volume":"17","author":"Haas","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1432-2277.2012.01447.x","article-title":"Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy","volume":"25","author":"Morath","year":"2012","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1423-0410.1991.tb00954.x","article-title":"Kinetic aspects of the removal of IgG and inhibitors in hemophiliacs using protein A immunoadsorption","volume":"61","author":"Gjorstrup","year":"1991","journal-title":"Vox Sang"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0955-3886(94)90174-0","article-title":"Technical and clinical experience with protein A immunoadsorption columns","volume":"15","author":"Belak","year":"1994","journal-title":"Transfus Sci"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/TP.0b013e31824836ae","article-title":"ABO-Incompatible Kidney Transplantation Enabled by Non-Antigen-Specific Immunoadsorption","volume":"93","author":"Morath","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/blood-2002-01-0128","article-title":"Influence of plasma immunoglobulin level on antibody synthesis","volume":"100","author":"Goldammer","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1567-5688(09)71824-0","article-title":"Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity","volume":"10","author":"Biesenbach","year":"2009","journal-title":"Atheroscler Suppl"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/TP.0b013e3181a6bac5","article-title":"Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection","volume":"87","author":"Fehr","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/01.tp.0000282786.58754.2b","article-title":"Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection","volume":"84","author":"Steinmetz","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-6143.2011.03830.x","article-title":"Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period","volume":"12","author":"Kohei","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/TP.0b013e3181d9e1c0","article-title":"Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidates","volume":"89","author":"Wahrmann","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/eji.200737743","article-title":"Dampening Ab responses using proteasome inhibitors following in vivo B cell activation","volume":"38","author":"Cascio","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0161-5890(96)00078-8","article-title":"Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv","volume":"33","author":"Thomas","year":"1996","journal-title":"Mol Immunol"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1600-6143.2011.03821.x","article-title":"Transplant accommodation-are the lessons learned from xenotransplantation pertinent for clinical allotransplantation?","volume":"12","author":"Dorling","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1600-6143.2010.03340.x","article-title":"Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches","volume":"11","author":"Cecka","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/TP.0b013e3181c626e1","article-title":"The altruistic unbalanced paired kidney exchange: proof of concept and survey of potential donor and recipient attitudes","volume":"89","author":"Ratner","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-6143.2004.00653.x","article-title":"ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab","volume":"5","author":"Tyden","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1600-6143.2009.02612.x","article-title":"Mechanisms of alloantibody production in sensitized renal allograft recipients","volume":"9","author":"Stegall","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/TP.0b013e3181a44206","article-title":"Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts","volume":"87","author":"Lachmann","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/TP.0b013e3181c3503e","article-title":"Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection","volume":"89","author":"Gill","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra0902927","article-title":"Rejection of the kidney allograft","volume":"363","author":"Nankivell","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1034\/j.1600-6143.2003.00135.x","article-title":"Humoral theory of transplantation","volume":"3","author":"Terasaki","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/TP.0b013e31817fdddb","article-title":"Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant","volume":"86","author":"Opelz","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1600-6143.2011.03961.x","article-title":"Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation","volume":"12","author":"Liefeldt","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/TP.0b013e3181ea3985","article-title":"An integrative approach for the transplantation of high-risk sensitized patients","volume":"90","author":"Morath","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1399-0039.2011.01638.x","article-title":"Current approaches to the management of highly sensitized kidney transplant patients","volume":"77","author":"S\u00fcsal","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.TP.0000080685.31697.FC","article-title":"Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients","volume":"76","author":"Jordan","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/01.tp.0000284729.39137.6e","article-title":"Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody","volume":"84","author":"Higgins","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/TP.0b013e3181919a16","article-title":"Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience","volume":"87","author":"Thielke","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1600-6143.2008.02524.x","article-title":"Positive cross-match living donor kidney transplantation: longer-term outcomes","volume":"9","author":"Haririan","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01490.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00423-011-0759-x","article-title":"Kidney transplantation in highly sensitized patients: are there options to overcome a positive crossmatch?","volume":"396","author":"Morath","year":"2011","journal-title":"Langenbecks Arch Surg"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2012.01490.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2012.01490.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:37:28Z","timestamp":1641062248000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2012.01490.x"}},"subtitle":["Prevention of antibody-mediated rejection"],"short-title":[],"issued":{"date-parts":[[2012,5,15]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2012.01490.x","relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,15]]}}}